Journal articleClin Nutr ESPEN2018
Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
- Journal
- Clin Nutr ESPEN
- Published
- 4 May 2018
- Citations
- 8
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background For those diagnosed with pancreatic cancer, ill-addressed pancreatic exocrine insufficiency (PEI) following surgery can result in malnutrition related complications that may impact on predict mortality and morbidity. The use of pancreatic enzyme replacement therapy (PERT) is recommended and often demands a degree of patient self-management. … Excerpt only: this text is the publisher’s. Read it in full at the source.